Resources

Urbanization in India has led to rapidly changing and diverse health needs, requiring adaptive and responsive urban health systems. However, despite initiatives such as National Urban Health Mission, dedicated health grants under Fifteenth Finance Commission, and Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, persistent systemic challenges, including low community awareness of primary health services, fragmented governance across multiple departments, and weak community structures, continue to hinder comprehensive health care delivery. Existing community platforms have not sufficiently evolved to align with newer comprehensive primary health care initiatives at urban health facilities, including Urban Primary Health Centres (UPHCs) and Urban Ayushman Arogya Mandirs (UAAMs), resulting in limited uptake of services and inadequate responses to emerging public health threats. To address this gap, the National Health Mission (NHM) established Mahila Arogya Samitis (MAS) and Jan Arogya Samitis (JAS), though variably functional, offer a critical opportunity for participatory governance. This project seeks to activate and strengthen MAS and JAS in Bokaro, Jharkhand, through a systems-design approach that fosters convergence with Urban Local Bodies, establishes clear linkages and escalation pathways, and enables these community institutions to play an effective role in local health governance and community development.

Cholera remains a growing global public health threat, and the WHO-endorsed Controlled Temperature Chain (CTC) offers a practical way to improve access to oral cholera vaccines in high-risk, low-resource settings. This guidance brief describes how CTC allows eligible oral cholera vaccines to be stored and transported outside the standard 2–8°C cold chain for defined periods, reducing logistical barriers and enabling faster, more equitable delivery. Drawing on implementation experience from Bangladesh, Mozambique, and Zambia, the document outlines operational requirements, safety considerations, and key lessons learned, demonstrating that CTC can be safely applied to increase vaccination coverage, reduce costs, and support effective cholera outbreak prevention and response.

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools now recommended for global use by the World Health Organization (WHO) could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, WHO and PATH have developed a toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations. Other expert contributors include the US Centers for Disease Control and Prevention, Seattle Children's Hospital/University of Washington, UMC Utrecht, the International Vaccine Access Center (IVAC), RRD Design, and more.To accommodate varying audience and engagement needs, this toolkit includes a stand-alone RSV primer presentation (and fact sheet) providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.Additional social media tools make sharing information about RSV with your network easy!To learn more about the toolkit, visit the web page.NOTE: Files available here as read-only. Editable files are readily available upon request. Please contact us.

The Rotary Healthy Communities Challenge (RHCC) project is supporting community health workers (CHWs) in Nigeria, the Democratic Republic of the Congo, Zambia, and Mozambique to implement integrated community case management in their communities. Integrated community case management is a globally recognized strategy to equip CHWs with the training and tools to diagnose, treat, and refer cases of malaria, pneumonia, and diarrhea.In the flow charts below, learn about the selection, training, and deployment process for CHWs in each country to implement integrated community case management.

This is a simple, Excel-based tool for assessing and comparing costs of human papillomavirus (HPV) vaccination programs with each HPV vaccine product available in the global market. It aims to help national-level policymakers specifically in middle-income countries compare products and estimate vaccination program costs for different HPV vaccines, exploring up to four different vaccine options at a time. The tool calculates cold chain volume and costs annually and for a total period of five years. Cost estimates are composed of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery).It is important to note that cost is only one consideration when selecting an HPV vaccine product, and users involved in decision-making around new vaccine introduction/switch or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages. Please be sure to check out this six-minute tutorial video, which is in English, with French and Spanish subtitled versions also available. If you have additional questions or need support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.NOTE: Please refer to this web page for the most up-to-date version of the calculator, which is periodically updated to reflect the evolving vaccine landscape.